Thank you, Mark, and thank you, everyone, for joining our call today. Turning to our fourth quarter earnings. We reported net income of $2 million or $0.03 per diluted share. Core FFO was $21.2 million or $0.30 per diluted share, and AFFO was $21.6 million or $0.31 per diluted share, which represented 7% year-over-year growth. For the full year, we reported net income of $0.11 per diluted share, core FFO of $1.19 per diluted share and AFFO of $1.22 per diluted share, which represented 5% growth year-over-year in 2023. Total G&A expense, excluding onetime items, was $4.8 million for the quarter, which was down 5.5% sequentially. In addition, total G&A for the quarter represented 13% of total revenues which [indiscernible] compared to last quarter and the prior year quarter when total G&A was 14.9% and 16.8%, respectively, of total revenues. We continue to expect our G&A to rationalize relative to our asset base and total revenues as the company has reached proper scale to effectively operate our business on a go-forward basis. Moving on to the balance sheet. Total net debt was $583.4 million at quarter end, and our weighted average interest rate was 4.3%. In addition, when including the impact of extension options, which are solely at our discretion, we have no debt maturing until January of 2027. In terms of future debt issuance, please note that in early March, we plan to draw the remaining $100 million of our 2029 term loan, which has been swapped to a fixed 5.13% interest rate. We do not anticipate raising any additional debt capital this year as our $400 million revolving credit facility provides us with ample capacity to fulfill our 2024 debt needs. With regards to fourth quarter capital markets activities, we raised $76.7 million of equity through our ATM program. In terms of forward agreements, we had $98.6 million of unsettled forward equity at 2023 year-end. As Mark mentioned earlier, subsequent to year-end, we raised just over 11 million shares of common stock in January of this year, which resulted in $190.8 million of net proceeds to the company. The offering was completed on a 100% forward basis, and we have until January 9, 2025, to settle all shares under the forward sale agreement. With that in mind, we now have the necessary equity capital to fund our 2024 external growth objectives without the need for any additional equity issuance. At quarter end, our liquidity was $548.4 million which was comprised of $29.9 million of cash on hand, $319.9 million available on our revolving credit facility, $98.6 million of available forward equity and $100 million of remaining available principal on our 2029 term line. Including the net proceeds from our January follow-on offering, our pro forma liquidity at year-end was $739.1 million. From a leverage perspective, our adjusted net debt to annualized adjusted EBITDAre was 4.1x at quarter end, which compares favorably to our targeted range of 4.5x to 5.5x. Furthermore, when including the net proceeds from our foreign offering this January, our quarter end pro forma leverage declines to 2.5x. Moving on to guidance. We are reaffirming our 2024 AFFO per share guidance range of $1.24 to $1.28. And we continue to expect cash G&A to range between $13.5 million and $14.5 million, which is exclusive of transaction costs and onetime severance payments. Lastly, on February 13, the Board declared a quarterly cash dividend of $0.205 per share. The dividend will be payable on March 28 to shareholders of record as of March 15. Based on the dividend amount, our AFFO payout ratio for the fourth quarter was 66%. With that, operator, we will now open the line for questions.